PortfolioPortfolio mode

ABT

Abbottstock

$102.860.23% today

Trade ABT

← Research only mode

Research ABT

ABT · 90-day price history

Market cap

$178.4B

P/E

38.3

Div yield

2.44%

Industry

Medical Devices

Exchange

NYSE

Website ↗

Prediction models

All predictions →

Trend follower

Horizon: 1 week

down

Signal strength0.24

Historical accuracy52%

100 predictions · 12mBaseline 43%

How this works

Compares a 10-day vs 50-day moving average. When the short-term average rises above the long-term average, the trend is up.

Not financial advice. Past accuracy does not guarantee future results.

Momentum

Horizon: 1 week

down

Signal strength0.10

Historical accuracy33%

100 predictions · 12mBaseline 43%

How this works

Uses RSI (a gauge of recent buying/selling intensity) and 5-day rate-of-change to judge whether the stock has been pushed too far in one direction.

Not financial advice. Past accuracy does not guarantee future results.

Statistical trend

Horizon: 1 month

down

Signal strength0.60

Historical accuracy25%

83 predictions · 12mBaseline 45%

How this works

Fits a trend line through the last 60 days of prices and measures how far the current price has strayed from it.

Not financial advice. Past accuracy does not guarantee future results.

Multi-factor + news

Horizon: 1 week

AI + NEWS

down

Signal strength0.25

Historical accuracy26%

38 predictions · 12mBaseline 43%

Accuracy reflects technical signals only. News sentiment is live.

How this works

Combines trend (25%), momentum (25%), volume (15%), and AI-analysed news sentiment (35%) from your trusted sources into one score.

Not financial advice. Past accuracy does not guarantee future results.

Bull / Bear thesis

AI analysis

Bull case●

Stock provides entry opportunity

Down 1.7% from recent highs may create value

Price action

Diversified medtech portfolio

Abbott serves multiple healthcare segments

Price action

Dividend history provides stability

Long dividend-paying history mentioned in peer reviews

Price action

Bear case●

Rating downgrade from buy to hold

Argus Research downgraded Abbott to Hold from Buy

Fintel

Significant stock decline

Down 1.7% reflects market concerns

Price action

Analyst concern about momentum

Downgrade suggests limited near-term upside

Fintel

AI-generated from recent news and price action. Not financial advice. Educational only.

Seasonality

~5y of history

Avg return by month · %

This month historically: -1.42% on average, up 40% of 5 years.

Avg return by weekday · %

Historical pattern only — seasonality is not a prediction and often breaks.

Recent news

Argus Research Downgrades Abbott Laboratories to Hold from Buy

Fintel · Oct 27

Downgrade from Buy to Hold signals analyst concern about valuation.

AI research companion

AI Research Companion

Loading…